Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
The Effect of High-Volume Walking With Visual Cues (VC) in Parkinson´s Disease (PD)
ClinicalTrials.gov study NCT01391741. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Telemedicine Intervention in Patients With Chronic Pain in PD
ClinicalTrials.gov study NCT05410392. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
ClinicalTrials.gov study NCT04157985. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of AK112, a PD-1/ VEGF Bispecific Antibody, for Resectable Hepatocellular Carcinoma With High Recurrence Risk
ClinicalTrials.gov study NCT06930573. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT04606472. IPD Sharing: Not stated. Countries: 1. Publications: 0.
To Compare the Safety and PK/ PD Characteristics of ADC189 Between Hepatic Impairment and Normal Hepatic Function Subjects
ClinicalTrials.gov study NCT06485401. IPD Sharing: NO. Countries: 1. Publications: 0.
Adjuvant Chemotherapy and Anti-PD-1 Antibody in Patients With Stage IIIC2-IVB Cervical Cancer
ClinicalTrials.gov study NCT04918628. IPD Sharing: NO. Countries: 1. Publications: 0.
Golidocitinib in Combination With Sintilimab for PD-L1 Selected Treatment Locally Advanced or Metastatic Non-Small Cell Lung Cancer(NSCLC)
ClinicalTrials.gov study NCT06198907. IPD Sharing: NO. Countries: 1. Publications: 0.
Therapeutic Vaccine Plus PD-1 Knockout in Prostate Cancer Treatment
ClinicalTrials.gov study NCT03525652. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Compare PK, PD and Safety of the AD-213-A and AD-2131
ClinicalTrials.gov study NCT04690868. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety, Tolerability, PK, PD of Escalating Single and Multiple Oral Doses of CJ-12420 in Healthy Male Subjects
ClinicalTrials.gov study NCT01473173. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Tarlatamab in Combination With YL201 With or Without Anti-programmed Death Ligand 1 (PD-L1) in Participants With Extensive Stage (ES) Small Cell Lung Cancer (SCLC)
ClinicalTrials.gov study NCT06898957. IPD Sharing: YES. Countries: 10. Publications: 0.
A Drug-Drug Interaction Study To Investigate The Potential For Multiple Doses Of Palbociclib (PD-0332991) To Alter The Pharmacokinetics Of Oral Midazolam In Adult Healthy Women of Non-Childbearing Pot
ClinicalTrials.gov study NCT01756781. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Programmed Cell Death Protein-1 (PD-1) Monoclonal Antibody for EBV-HLH and CAEBV as First-line Therapy
ClinicalTrials.gov study NCT05039580. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Compare PK, PD and Safety of the AD-206 and Esomeprazole
ClinicalTrials.gov study NCT03980756. IPD Sharing: NO. Countries: 1. Publications: 0.
Longitudinal Investigation of I2BS in PD
ClinicalTrials.gov study NCT05516719. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody
ClinicalTrials.gov study NCT03975036. IPD Sharing: Not stated. Countries: 1. Publications: 0.
GP Chemotherapy in Combination With Anti-PD-1 and Anti-TIGIT in Unresectable Advanced BTC
ClinicalTrials.gov study NCT05023109. IPD Sharing: NO. Countries: 1. Publications: 0.
Frequency Effect of STN-DBS Through the Dual System on FOG in PD
ClinicalTrials.gov study NCT04285099. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of ADG106 In Combination With PD-1 Antibody In Advanced or Metastatic Solid Tumors and/or Non Hodgkin Lymphoma
ClinicalTrials.gov study NCT04775680. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.